Invictus MD Strategies Corp. CEO’s Update to Shareholders

Posted on Categories: Investor Relations

VANCOUVER, BC, January 26, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Chairman and CEO Dan Kriznic is pleased to provide this update to it’s shareholders.

2016 was a transformational year for Invictus MD. The Company’s majority interest in Future Harvest Development Ltd. (“FHD”), initially purchased in February 2015, has performed exceptionally well. FHD produced record sales in 2016 as the burgeoning market for commercial hydroponics products continued to show an appetite for FHD’s unique lines of nutrients and equipment. Despite 50% year over year sales growth in 2016, the company is confident that FHD’s best growth is still ahead. The timely acquisition of a bottling line and exceptional performance and leadership of key hires are leading an expansion into the fertilization sector, where key growth opportunities have been identified. Under the direction of Chris Pearson and newly hired research consultant from the University of British Colombia Dr. Paul Shipley, and head bioengineer Justin Pearson, FHD’s Plant Life Products and Holland Secret brands are successfully competing for and winning fertilizer market share. The fertilizer brands, along with the continuing success of companion metering product Grow Boss is earning the company a significant and growing position in the commercial hydroponics market.

Read more “Invictus MD Strategies Corp. CEO’s Update to Shareholders”

Invictus MD Strategies Corp. Announces the Appointment of Larry Heinzlmeir as Vice President, Marketing and Communications

Posted on Categories: Investor Relations

VANCOUVER, BC, January 24, 2017 – INVICTUS MD STRATEGIES CORP. (Invictus MD) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that Larry Heinzlmeir has joined the company as Vice President of Marketing and Communication, reporting to Chairman and CEO Dan Kriznic.

Heinzlmeir is an authority on digital marketing, online platforms and brand strategy. He joins Invictus MD with more than 25 years of executive level experience in sales and marketing, driving substantial growth for several of the largest publicly traded companies in the for-profit higher education sector, including DeVry and EDMC.

Read more “Invictus MD Strategies Corp. Announces the Appointment of Larry Heinzlmeir as Vice President, Marketing and Communications”

Invictus MD announces binding LOI to acquire PlanC BioPharm Inc., a Late Stage Applicant under Health Canada’s ACMPR

Posted on Categories: Investor Relations

VANCOUVER, BC, January 17, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has entered into a binding letter of intent (“LOI”) to acquire 100% of PlanC BioPharm Inc. (“PlanC”), a Late Stage Applicant under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

PlanC is currently in active final review stage with Health Canada for an application that was submitted in 2014 based on a proposed initial 30,000 square foot, state-of-the-art, medicinal cannabis production and processing facility located on 5 acres just outside Salmo, British Columbia (the “Property”). Invictus MD will issue to the PlanC shareholders $100,000 in cash and 50,000 common shares to a maximum value for such common shares of $70,000 as consideration for entering into the LOI. In addition, Invictus MD will pay $100,000 in cash and 100,000 in common shares to a maximum value for such common shares of $175,000 as consideration for signing a definitive agreement (“the Definitive Agreement”).

Read more “Invictus MD announces binding LOI to acquire PlanC BioPharm Inc., a Late Stage Applicant under Health Canada’s ACMPR”